Stocksigma LogoStocksigma Logo

Ennature Bio Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Ennature Bio Pharma Limited will hold a Board of Directors meeting on 12th Nov'26 to consider and approve the company's unaudited financial results for the

Ennature Bio Pharma Schedules Board Meeting for Q2 FY27 Financial Results

Ennature Bio Pharma Limited 路 Intimation 路 12 Nov 2026, 5:30 am

Ennature Bio Pharma Schedules Board Meeting for Q2 FY27 Financial Results Ennature Bio Pharma Limited will hold a Board of Directors meeting on 12th Nov'26 to consider and approve the company's unaudited financial results for the quarter ended 30th Sep'26. In accordance with its Code of Conduct for insider trading regulations, the trading window for dealing in company securities remains closed from 4th Nov'26 through 14th Nov'26 (both days inclusive).

Original exchange filing (PDF)

More announcements from Ennature Bio Pharma Limited

  • Please find attached. 路 12 Nov 2026
  • Please find attached. 路 12 Nov 2026
  • Ennature Bio Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
  • Please find attached. 路 12 Nov 2026
  • Please Find attached 路 12 Nov 2026
  • ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 12 Nov 2026
  • ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 12 Nov 2026
  • To consider and approve the financial results for the period ended September 30, 2026 路 12 Nov 2026

All Ennature Bio Pharma Limited announcements